Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

TheraSense buy leads Abbott to cut MediSense jobs:

This article was originally published in Clinica

Executive Summary

Abbott Laboratories' $1.1bn acquisition of blood glucose monitoring specialist TheraSense will result in the loss of around 400 jobs in Bedford, Massachusetts, where Abbott's existing diabetes outfit, MediSense, is based. The company intends to move all its diabetes monitoring operations to Alameda, California, where TheraSense is based. About 100 of the 500 MediSense staff will be offered alternative employment; the rest will receive severance or retirement packages. Abbott Park, Illinois-based Abbott intends to establish a new division, Abbott Diabetes Care, which will be headed by Ed Fiorentino, current president of MediSense.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT057793

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel